- Home
- FXNC vs RNA Comparison
FXNC vs RNA Comparison
Compare FXNC & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FXNC | RNA |
|---|---|---|
| Founded | 1907 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 251.5M | 211.6M |
| IPO Year | 2012 | 2025 |
Fundamental Metrics
Financial Performance| Metric | FXNC | RNA |
|---|---|---|
| Price | $30.55 | $13.55 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 20 |
| Target Price | N/A | ★ $69.26 |
| AVG Volume (30 Days) | 94.6K | ★ 213.5K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.43% | N/A |
| EPS Growth | ★ 96.00 | N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | ★ $7,717,000.00 | N/A |
| Revenue This Year | $12.21 | $88.12 |
| Revenue Next Year | $2.93 | $18.11 |
| P/E Ratio | $55.63 | ★ N/A |
| Revenue Growth | ★ 7.40 | N/A |
| 52 Week Low | $20.10 | $11.40 |
| 52 Week High | $31.21 | $73.06 |
Technical Indicators
Market Signals| Indicator | FXNC | RNA |
|---|---|---|
| Relative Strength Index (RSI) | 56.58 | 59.91 |
| Support Level | $28.90 | $12.56 |
| Resistance Level | $30.86 | $14.05 |
| Average True Range (ATR) | 0.87 | 0.47 |
| MACD | 0.03 | 0.18 |
| Stochastic Oscillator | 49.35 | 90.85 |
Price Performance
Historical ComparisonAbout FXNC First National Corporation
First National Corp is a bank holding company of First Bank, which is a commercial bank. Its core offering includes loans, deposits, wealth management, and other products and services. The Company operates through two reportable operating segments: Community Banking and wealth management. The Community Banking segment involves making loans and generating deposits from individuals, businesses, and charitable organizations. Wealth Management Services offers corporate trustee services, trust and estate administration, IRA administration and custody services. The company has revenue from Community Banking segment.
About RNA Avidity Biosciences Inc.
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.